An HCP education and engagement platform

Connecting the dots in rare disease education

NIRDs connects healthcare professionals with focused education, expert perspectives, and timely updates on rare disease diagnosis, management, therapies, and clinical research.

Filling the Knowledge Gap to Advance Rare Disease Care

Engage

Advisory boards and consensus panels

Expert roundtables and focus groups that generate publishable insight and real-world data.

Educate

Webinars and national conferences

Targeted online webinars and flagship annual conferences with each specialty.

Reach

Accredited CME on the big stages

Dedicated podium time and satellite symposia at the field's largest, most established meetings.

A Multidisciplinary Approach

Novel Insights in Rare Diseases is a hub for healthcare-professional education in rare and immune-mediated disease. It is organized into specialty sections, each running its own education, engagement and industry-collaboration programs.

Rare diseases are often under-recognized precisely because they sit between disciplines. NIRDs closes that gap the same way in every section: convene the clinicians who see these patients, ground the discussion in real data, and keep the field current as new therapies arrive.

Every specialty, its own program

  • Dermatology

    • NIRDs Rare Disease Dermatology Conference. November 13 to 15, 2026.
    • AAD 2026 and 2027. A directed, accredited forum at the world's largest dermatology meeting.
    • Maui Derm, four meetings across 2026 and 2027. One dedicated educational hour at each, spanning NP, PA and physician audiences.
  • Rheumatology

    • Basic and Clinical Immunology for the Busy Clinician. Cleveland Clinic. Las Vegas, February 2027.
    • Biologic Therapies Summit. Cleveland, May 2027.
  • Gastroenterology

    • Monthly CME webinar series. Year-round, online.
  • Oncology

    • From Lesion to Systemic Therapy. CME satellite symposium adjunct to ASCO 2026. Chicago, May 29, 2026.

Pulmonary Medicine, Allergy and Immunology coming in 2027.